Free Trial

Eterna Therapeutics (ERNA) SEC Filings & 10K Form

Eterna Therapeutics logo
$0.17 -0.05 (-22.93%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.18 +0.01 (+3.21%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Eterna Therapeutics SEC Filings

DateFilerForm TypeView
03/26/2025
6:30 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/17/2024
11:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form EFFECT
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form ARS
09/27/2024
3:47 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form PRE 14A
09/27/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:14 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ERNA) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners